Similar articles

• [Survival after myocardial infarction in the nineties. Results of a prospective registry and their implications as to identification of an increased risk of death and especially sudden death].

  Jordaens L, Tavernier R. Jordaens L, et al. J Med Liban. 1999 May-Jun;47(3):181-9. J Med Liban. 1999. PMID: 10550944 Review. French. No abstract available.
• Prevention of myocardial reinfarction. Recommendations based on results of drug trials.

  Flaker GC, Singh VN. Flaker GC, et al. Postgrad Med. 1993 Nov 1;94(6):94-8, 102-4. Postgrad Med. 1993. PMID: 7901845 Review.
• Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.

  Eisenberg MJ, Okrainec K, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Duerr R, Tsang J, Huynh T, Sedlis S, Brown DL, Brieger D, Pilote L; ROSETTA Investigators. Eisenberg MJ, et al. Can J Cardiol. 2003 Aug;19(9):1009-15. Can J Cardiol. 2003. PMID: 12915928
• Secondary prevention of ischaemic cardiac events.

  Gami A. Gami A. Clin Evid. 2006 Jun;(15):195-228. Clin Evid. 2006. PMID: 16973010 Review. No abstract available.
• [Drug therapy as secondary prevention following myocardial infarction].

  Cottier C. Cottier C. Praxis (Bern 1994). 1996 Apr 23;85(17):545-7. Praxis (Bern 1994). 1996. PMID: 8668892 German. No abstract available.